Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
May 18, 2016
0
8
Swiss drugmaker Novartis said Thursday it had reached a deal with US authorities to pay $25 million (22.4 million euros) to settle claims that its Chinese units bribed healthcare professionals to boost sales, including with ...
Mar 24, 2016
0
1
Swiss drug maker Novartis says it will cooperate with California-based biotech giant Amgen to develop and sell neuroscience treatments for illnesses and ailments like Alzheimer's disease and migraine headaches.
Sep 2, 2015
0
12
A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication.
Jul 21, 2015
0
4
Swiss pharmaceutical giant Novartis reported $4.1 billion (3.8 billion euros) in income for the first half of the year, down 20 percent, due largely to a stronger dollar.
Jul 21, 2015
0
9
Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients.
Jul 7, 2015
0
6
US authorities are seeking up to $3.3 billion (three billion euros) in fines from Swiss pharmaceutical giant Novartis on allegations it paid kickbacks to boost drug sales, according to a document AFP consulted Wednesday.
Jul 1, 2015
0
8
Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the U.S. drugmaker valued at about $130 million.
Jun 22, 2015
0
3
British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.
May 6, 2015
0
5
Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.
Apr 23, 2015
0
7
